Skip to content
What if… We were able to define diseases in terms of imbalances in biological processes and systems across different tissues and organs?
It turns out… We can use novel combinations of the body’s own biological molecules as safe, natural modulators to address those imbalances and a variety of diseases.

Founded by Flagship Pioneering in 2011, Axcella is a biotechnology company pioneering a new way to harness the power of endogenous metabolic modulators, or EMMs, with the goals of reprogramming metabolism and restoring metabolic health to treat a broad range of complex diseases and health conditions in ways that are simply not possible with currently available interventions.

Latest News from Axcella Therapeutics